Table 1 Demographics, molecular results, and psychiatric features.
Case | Category | Age | CGG repeats | mRNA (SD) | FMRP | Full scale IQ | Dominant psychiatric feature |
|---|---|---|---|---|---|---|---|
1 | A | 9 | 150 | 2.56 (0.27) |
| 86 (WISC-IV) | Mood instability, ADHD |
2 | C | 53 | 180–690 | 3.85 (0.30) |
| 101 (WAIS-III) | Bipolar disorder NOS |
3 | B | 36 | 205 | 2.59 (0.1) | 6.04 | 51 (WAIS-III) | ADHD, schizophrenia, ID |
4 | B | 28 | 226 (260–445) | 3.85 (0.43) |
| 117 (WAIS-III) | Social phobia, OCD, schizotypical symptoms |
5 | C | 58 | 20–800 | 2.98 (0.06) |
| 84 (WAIS-IV) | Bipolar I, OCD, panic disorder, generalized anxiety |
6 | B | 25 | 570, 730, 1090 (240) | 3.3 (0.04) | 33.75 | 61 (WAIS-III) | ASD, Social Phobia, auditory hallucinations, ID |
7 | B | 22 | 255 (270–535) | 5.79 (0.13) | 47.33 | 65 (WASI) | Psychosis in past, anxiety disorder, OCD, ID |
8 | B | 22 | 215, 900 (220, 335) | 2.30 (0.16) | 13.42 | 45 (WISC-IV) | Social phobia, ASD symptoms, ID |
9 | D | 23 | 160–190 | 5.02 (0.49) | 70.00 | 86 (WISC-III) | ASD, psychosis |
10 | D | 19 | 170 | 4.98 (0.32) | 36.00 | 54 (WAIS-III) | ASD, paranoid thinking, anxiety disorder, ID |
11 | D | 57 | 133 | 3.59 (0.28) |
|
| ASD, past ADHD |
12 | D | 24 | 67 | 2.40 (0.23) | 18.30 | 110 (WAIS-III) | ASD, bipolar II disorder, OCD |
13 | C | 27 | 570, 750, 890 (104) | 2.38 (0.05) |
| 60 (SB5) | Anxiety disorder, ID, “socially awkward” |
14 | D | 34 | 88 | 2.8 (0.18) |
| 107 (WAIS-III) | Biploar I disorder, substance abuse, stress disorder, past ADHD |








data not available.